0001209191-18-062126.txt : 20181211
0001209191-18-062126.hdr.sgml : 20181211
20181211194900
ACCESSION NUMBER: 0001209191-18-062126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181207
FILED AS OF DATE: 20181211
DATE AS OF CHANGE: 20181211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Owens Julia C.
CENTRAL INDEX KEY: 0001760219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 181229875
MAIL ADDRESS:
STREET 1: C/O OVASCIENCE, INC.
STREET 2: 9 FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-07
0
0001544227
Millendo Therapeutics, Inc.
MLND
0001760219
Owens Julia C.
C/O MILLENDO THERAPEUTICS, INC.
301 N. MAIN ST., SUITE 100
ANN ARBOR
MI
48104
1
1
0
0
President and CEO
Common Stock
2018-12-07
4
A
0
74400
A
74400
D
Employee Stock Option (right to buy)
1.08
2018-12-07
4
A
0
60179
A
2022-08-29
Common Stock
60179
60179
D
Employee Stock Option (right to buy)
4.44
2018-12-07
4
A
0
151600
A
2026-01-27
Common Stock
151600
151600
D
Employee Stock Option (right to buy)
16.40
2018-12-07
4
A
0
174839
A
2028-08-23
Common Stock
174839
174839
D
Received in exchange for 1,000,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
Fully vested.
Received in connection with the Merger in exchange for a stock option to acquire 808,867 shares of Millendo common stock for $0.08 per share.
Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Received in connection with the Merger in exchange for a stock option to acquire 2,037,648 shares of Millendo common stock for $0.33 per share.
Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Received in connection with the Merger in exchange for a stock option to acquire 2,350,000 shares of Millendo common stock for $1.22 per share.
/s/ Jeffery M. Brinza, Attorney-in-Fact
2018-12-11